James Daniel Guylain Priour
Profile
James Daniel Guylain Priour worked as a General Manager in Hungary for Bristol Myers Squibb Co. and as a Sales Manager for Procter & Gamble Co. He also worked as the Chief Commercial Officer for Zymeworks BC, Inc. from 2021 to 2022, and as the Head-General Medicine for Amgen France.
Additionally, he worked as a General Manager for Amgen Australia Pty Ltd.
Priour holds an MBA from NEOMA Business School.
Former positions of James Daniel Guylain Priour
Companies | Position | End |
---|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 2022-01-18 |
Amgen Australia Pty Ltd. | Corporate Officer/Principal | - |
Amgen France | Corporate Officer/Principal | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
PROCTER & GAMBLE COMPANY | Sales & Marketing | - |
Training of James Daniel Guylain Priour
NEOMA Business School | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
Private companies | 3 |
---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Amgen France | |
Amgen Australia Pty Ltd. |
- Stock Market
- Insiders
- James Daniel Guylain Priour